Additional information
Active substance | Anastrozole |
---|---|
Trade name | Arimidex |
Side effects | Hot flashes, joint symptoms, weakness, mood changes, bone loss, increased risk of osteoporosis |
Effects | Reduces estrogen levels, useful in the treatment of estrogen receptor-positive breast cancer |
Dosage (sports) | Not commonly prescribed for sports uses, but dosages in unofficial contexts can vary |
Dosage (medical) | Typically 1 mg per day |
Half-life | Approximately 50 hours |
Main action | Inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens |
Substance class | Aromatase inhibitor |
Formula | C17H19N5 |
Chemical name | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropiononitrile) |
Storage conditions | Store at room temperature away from moisture and heat |
Blood pressure | Can sometimes lower blood pressure due to reduced estrogen levels |
WAREHOUSE | USA Warehouse 3 |
Also known as | Anastrozol |
Lab Test | See Document |
Aromatization | No |
Hepatotoxicity | No |
HBR | No |
Water Retention | No |
Acne | No |
Dosage | 0.5-1 mg/day |
Classification | Non-steroidal aromatase inhibitor |
Active Half-Life | 2 days |
Use in sports | Sometimes used by bodybuilders to reduce the effects of estrogen related to the use of anabolic steroids |
Manufacturer | Euro-Pharmacies – US |
Reviews
There are no reviews yet.